Avalon GloboCare Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Quarterly Earnings Release (Form 10-Q) | 16 Nov 2026 |
| FY 2026 Annual Earnings Release (Form 10-K) | 31 Mar 2027 |
Monitoring Framework
Key Performance Indicators
Cash and Cash Equivalents Quarterly776KTarget: Sufficient to fund operations and eliminate going concern doubt
Quarterly Net Loss Quarterly-4.5MTarget: Reduction of net loss through commercialization of AI and KetoAir platforms
Working Capital Deficit Quarterly-2.8MTarget: Elimination of deficit through strategic financing and asset sales
Watch Items
- Going Concern StatusTrigger: Continued auditor explanatory paragraph in future filingsAction: Secure additional equity or debt financing, or generate substantial commercial revenues from KetoAir and the Catch-Up AI platform.
- Nasdaq Capital Market ComplianceTrigger: Stockholders' equity falling below $2.5 million or stock price below $1.00Action: Implement the approved reverse stock split or execute further capital raises to maintain listing requirements.
- Catch-Up AI Platform Phase 2 LaunchTrigger: Delay beyond Q3 2026 targetAction: Monitor development milestones with AWS Premier Tier partner Caylent to ensure timely commercialization.
Research as of 20 Jun 2026